Clinical Trial Update: A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aripiprazole lauroxil to paliperidone palmitate in schizophrenia has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)
• aripiprazole lauroxil (aripiprazole lauroxil)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2020-08-11